#1 Clinical Trials Search in Europe

Oxytocin Synthetic

Oxytocin Synthetic, a nasal spray medication, is currently being studied in clinical trials for its potential benefits in treating Autism Spectrum Disorder (ASD). These trials aim to investigate how this drug may affect neural plasticity, learning, social behavior, and repetitive behaviors in young people with ASD. The research focuses on intranasal administration of oxytocin and its impact on various aspects of autism, offering hope for new treatment options in the future.

Table of Contents

What is Oxytocin?

Oxytocin is a hormone naturally produced in the human body. It plays a crucial role in social bonding, childbirth, and breastfeeding. The synthetic version of oxytocin, known as Oxytocin Synthetic, is being studied as a potential treatment for various conditions, including Autism Spectrum Disorder (ASD).[1] [2]

Autism Spectrum Disorder

Autism Spectrum Disorder (ASD) is a developmental disorder that affects communication, social interaction, and behavior. People with ASD may have difficulty understanding social cues, forming relationships, and adapting to changes in their environment. The severity of symptoms can vary widely among individuals.[1] [2]

Oxytocin Research in Autism

Researchers are conducting clinical trials to investigate the potential benefits of Oxytocin Synthetic for individuals with ASD. These studies aim to determine if oxytocin can improve various aspects of autism-related symptoms.[1] [2]

How is Oxytocin Administered?

In the ongoing studies, Oxytocin Synthetic is administered as a nasal spray. This method allows the medication to be easily and non-invasively delivered. The dosage being tested ranges from 8 to 24 International Units (IU), which is a standardized measurement for biological substances.[1] [2]

Potential Benefits of Oxytocin

Researchers are investigating several potential benefits of Oxytocin Synthetic for individuals with ASD:

  • Neural plasticity: This refers to the brain’s ability to form new connections and adapt. Improved neural plasticity could potentially help individuals with ASD learn and adapt more easily.[1]
  • Cognitive flexibility: This is the ability to adapt to new situations and switch between different thoughts. Enhanced cognitive flexibility might help individuals with ASD handle changes in their environment better.[1]
  • Social behavior: Oxytocin may help improve social interactions and communication skills in individuals with ASD.[2]
  • Repetitive behaviors: The treatment might help reduce repetitive behaviors, which are common in ASD.[2]
  • Behavioral inflexibility: This refers to difficulty in adapting to changes. Oxytocin might help individuals become more flexible in their behaviors.[2]

Who is Eligible for Oxytocin Treatment?

The current studies are focusing on young people with ASD. Here are some key eligibility criteria:

  • Age range: 12 to 21 years old[1] or 12 to 20 years old[2]
  • Confirmed diagnosis of Autism Spectrum Disorder
  • Ability to understand and follow study instructions
  • Good general physical health
  • IQ of 70 or above

It’s important to note that these criteria are specific to the current research studies and may not reflect future treatment eligibility if oxytocin becomes an approved therapy for ASD.[1] [2]

Possible Side Effects and Precautions

While oxytocin is being studied for its potential benefits, it’s crucial to be aware of possible side effects and precautions:

  • Individuals with certain medical conditions, such as significant hepatic, renal, endocrine, cardiac, nervous, pulmonary, hematological, or metabolic disorders, may not be suitable for this treatment.[1] [2]
  • People with a history of nasal diseases or surgeries, or those dependent on inhaled drugs, may not be eligible.[1] [2]
  • Allergic reactions to components of the nasal spray (such as propyl parahydroxybenzoate, methyl parahydroxybenzoate, and chlorobutanol hemihydrate) or latex are contraindications.[1] [2]
  • The treatment is not suitable for pregnant or breastfeeding individuals.[1] [2]

As with any medication, it’s crucial to consult with a healthcare professional before considering oxytocin treatment. They can provide personalized advice based on an individual’s specific health condition and needs.

Aspect Details
Drug Name Oxytocin Synthetic
Administration Method Intranasal spray
Target Condition Autism Spectrum Disorder (ASD)
Age Groups Studied 12-21 years old
Main Study Objectives Effects on neural plasticity, learning, social behavior, and repetitive behaviors
Secondary Objectives Impact on cognitive flexibility, parasympathetic nervous system activity
Study Designs Randomized, placebo-controlled, double-blind, cross-over studies
Treatment Durations Single administration and four-week daily treatments
Key Measurements EEG, computerized tasks, behavioral scales, heart rate variability

FAQ

  • What is Oxytocin Synthetic and how is it administered in these trials? Oxytocin Synthetic is a medication being studied for its potential effects on Autism Spectrum Disorder. In these trials, it is administered as a nasal spray, which means it's sprayed into the nose for absorption.
  • What age groups are being studied in these clinical trials? The clinical trials are focusing on youth with Autism Spectrum Disorder. One study includes participants between the ages of 12 and 21, while another includes those between 12 and 20 years old.
  • What are the main objectives of these clinical trials? The main objectives include studying the effects of oxytocin on neural plasticity, learning, social behavior, and repetitive behaviors in individuals with ASD. Researchers are also looking at its impact on cognitive flexibility and parasympathetic nervous system activity.
  • How long do the treatments last in these studies? The duration varies between the studies. One trial involves a single administration of oxytocin, while another involves twice-daily doses for four weeks.
  • What are some of the key measurements being used in these trials? The trials use various measurements including EEG for neural plasticity, computerized tasks for cognitive flexibility and social cognition, heart rate variability for parasympathetic nervous system activity, and behavioral scales like the Social Responsiveness Scale and Repetitive Behavior Scale.

Ongoing Clinical Trials on Oxytocin Synthetic

  • Study on the Effects of Intranasal Oxytocin on Learning in Youth with Autism Spectrum Disorder

    Recruiting

    1 1
    Investigated drugs:
    Norway

  • Study on the Effects of Intranasal Oxytocin on Social and Repetitive Behaviors in Youth with Autism Spectrum Disorder

    Not yet recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Norway

Glossary

  • Autism Spectrum Disorder (ASD): A developmental disorder characterized by difficulties with social interaction, communication, and restricted or repetitive behaviors or interests.
  • Neural plasticity: The brain's ability to change and adapt in response to experiences or environmental stimuli.
  • Intranasal: Administered through the nose, typically as a spray or drops.
  • Oxytocin: A hormone that plays a role in social bonding, childbirth, and milk production in mammals.
  • Placebo: An inactive substance or treatment used as a control in an experiment or clinical trial.
  • Double-blind: A study design where neither the participants nor the researchers know who is receiving the active treatment or placebo.
  • Cross-over study: A type of clinical trial where participants receive different treatments in a specific order over time.
  • EEG (Electroencephalogram): A test that measures electrical activity in the brain using small electrodes attached to the scalp.
  • Cognitive flexibility: The ability to adapt thinking or attention in response to changing goals or environmental stimuli.
  • Parasympathetic nervous system: Part of the autonomic nervous system that helps the body relax and conserve energy.

References

  1. http://clinicaltrials.eu/trial/study-on-the-effects-of-intranasal-oxytocin-on-learning-in-youth-with-autism-spectrum-disorder/
  2. http://clinicaltrials.eu/trial/study-on-the-effects-of-intranasal-oxytocin-on-social-and-repetitive-behaviors-in-youth-with-autism-spectrum-disorder/